Journal of Thrombosis and Thrombolysis

, Volume 11, Issue 3, pp 183–193

Plasminogen Activator Inhibitor Type-1 (Part One): Basic Mechanisms, Regulation, and Role for Thromboembolic Disease

Authors

  • Kurt Huber
    • Department of CardiologyUniversity of Vienna, General Hospital
Article

DOI: 10.1023/A:1011955018052

Cite this article as:
Huber, K. J Thromb Thrombolysis (2001) 11: 183. doi:10.1023/A:1011955018052

Abstract

Plasminogen activator inhibitor type-1 (PAI-1) is a rapid inhibitor of tissue plasminogen activator (tPA) in circulation. Evidence suggests that the PAI-1 concentration is responsible for the regulation of the endogenous fibrinolytic system through its tPA/PAI-1 interactions. Accordingly, increased levels of PAI-1 have emerged as a masker for an increased thrombolic risk. This article represents a status report of mechansism of action, regulation of plasma levels, as well as the role of PAI-1 in arterial and venous thromboembolic disease.

PAI-1regulationthromboembolic disease

Copyright information

© Kluwer Academic Publishers 2001